Androgenic Therapy for Advanced Breast Cancer in Women
- 12 March 1973
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 223 (11) , 1267-1268
- https://doi.org/10.1001/jama.1973.03220110045012
Abstract
A randomized clinical trial of calusterone and testolactone according to the protocol of the Cooperative Breast Cancer Group (CBCG) produced objective remissions of advanced breast cancer in 28% of women receiving calusterone and 18% of those given testolactone. Effectiveness of the calusterone has prompted a dose-response study by the CBCG to determine the most effective dose of this androgen for use in treatment of breast cancer.Keywords
This publication has 1 reference indexed in Scilit:
- The Synthesis of Some 7α- and 7β-Methyl Steroid Hormones1Journal of the American Chemical Society, 1959